Skip To Main Content
Nan L. Xia on Muck Rack

Nan L. Xia

As seen in: Medium, National Institutes of Health, Nature, PLOS, PLOS Biology, PLOS ONE, BMJ Open, MDPI, BMC Cancer, China Daily (English) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nan L.

Contact Nan L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of acoustic startle priming on poststroke dysarthria rehabilitation: study protocol for a double-blinded, single-centre randomised controlled trial in China

|
By Mingzhu Wang, Nan L. Xia, Qiongfang Wu, Tingting Jiang
| BMJ Open Verified
Introduction Stroke is the leading cause of mortality and long-term disability worldwide.1 2 According to the 2021 Global Burden of Disease Study, approximately 7.3 million deaths annually are attributed to stroke, making it the third-leading cause of death globally.3 In China, where a significant proportion of stroke-related deaths occur, over 7 million stroke survivors face varying degrees of disability, with substantial impacts on their quality of life.4 Among the many sequelae of stroke,...
Open in Who Shared Issue with article?

Identification and validation of glucose metabolism-related gene signature in endometrial cancer - BMC Cancer

|
By Juan Jiang, Nan L. Xia, Mei Yang, Ping Qiu, Wei Zhu, JING CHEN, Jiamei Zhu
| BMC Cancer Verified
The mRNA expression profiles and clinical data for EC were obtained from the TCGA database (https://portal.gdc.cancer.gov/). This dataset included RNA-Seq expression matrices for 554 EC samples and 35 normal samples, and corresponding clinical information for 544 EC samples. The survival data for these 544 EC samples was also downloaded as of April 27, 2023.
Open in Who Shared Issue with article?

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer - Scientific Reports

|
By Nan L. Xia
| Nature Verified
Abstract The study aims to identify potential drug targets for endometrial cancer (EC) subtypes through a Mendelian randomization (MR) approach, assessing their clinical relevance. We utilized genetic instruments for 4,907 plasma proteins from the deCODE Genetics study dataset, and data with EC (n = 12,906) from a genome-wide study (GWAS) meta-analysis in European populations for MR analyses.
Open in Who Shared Issue with article?
See all 18 licensed articles (22 Total)